The Role of MYC and PP2A in the Initiation and Progression of Myeloid Leukemias
The MYC transcription factor is one of the best characterized PP2A substrates. Deregulation of the MYC oncogene, along with inactivation of PP2A, are two frequent events in cancer. Both proteins are essential regulators of cell proliferation, apoptosis, and differentiation, and they, directly and in...
Main Authors: | Raffaella Pippa, Maria D. Odero |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/3/544 |
Similar Items
-
Methylenetetrahydrofolate reductase polymorphisms in myeloid leukemia patients from Northeastern Brazil
by: Cynara Gomes Barbosa, et al.
Published: (2008-01-01) -
Hemophagocytosis by acute myeloid leukemia blasts associated to poor clinical outcomes
by: Zangbéwendé Guy Ouedraogo, et al.
Published: (2022-05-01) -
Matrine, a potential c-Myc inhibitor, suppresses ribosome biogenesis and nucleotide metabolism in myeloid leukemia
by: Wang-Jing Zhong, et al.
Published: (2022-10-01) -
Infant Acute Myeloid Leukemia: A Unique Clinical and Biological Entity
by: Charlotte Calvo, et al.
Published: (2021-02-01) -
WHO 2016 Definition of Chronic Myeloid Leukemia and Tyrosine Kinase Inhibitors
by: İbrahim C. Haznedaroğlu, et al.
Published: (2020-02-01)